Skip to content

A Study on Early Protective Efficacy of Rabies Antibody Post Standardized Management Among High-Risk Exposed Population in Real-World Settings

A Study on Early Protective Efficacy of Rabies Antibody Post Standardized Management Among High-Risk Exposed Population in Real-World Settings

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124587
Enrollment
Unknown
Registered
2026-05-14
Start date
2026-05-14
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rabies

Interventions

Rabies exposure Group:None

Sponsors

Hangzhou Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age 18 years or older on the day of enrollment, male or female, and able to provide valid legal identification; 2. Category III rabies virus exposure, with the time from signing the informed consent form less than 48 hours; 3. Completed the informed consent process before the study, and voluntarily agreed to and signed the informed consent form; 4. Capable of understanding the study procedures and expected to complete all follow-ups (no plan for long-term departure or relocation from the study site); 5. Body temperature <= 37.0 ?.

Exclusion criteria

Exclusion criteria: 1. History of vaccination with rabies vaccine, or injection with rabies virus passive immunizing agents including equine rabies immunoglobulin, purified equine F(ab')2 fragment products, and human rabies immunoglobulin (HRIG), as confirmed by inquiry; 2. Any other conditions that, in the investigator’s judgment, may increase the safety risks of the subject during the study.

Design outcomes

Primary

MeasureTime frame
Rabies neutralizing antibody (RVNA);Adverse Reaction;

Countries

China

Contacts

Public ContactWang Haiming

Hangzhou Third People's Hospital

wwanghmcf@163.com+86 571 87827263

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026